CompletedPhase 2

Pupil Dilation for Treatment of IFIS

United States13 participantsStarted 2019-01-04

Plain-language summary

A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Subjects with untreated hypertension or baseline BP \>160
✕. Subjects with Thyrotoxicosis
✕. Pregnant women or women trying to conceive
✕. Prisoners
✕. Inability consent
✕. Subjects with anatomical narrow angles or who have never had a dilated eye exam
✕. Subjects currently prescribed brimonidine tartrate for glaucoma
✕. Subjects who take topical or systemic alpha agonists

Pupil Dilation Sized of the Treated Eye Compared to the Non-treated Eye

Timeframe: 45 minutes post dilation after 7 days of treatment

NCT IDNCT03760185

SponsorDenver Health and Hospital Authority

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-09-25

Results submitted2021-12-10